Acute Lymphoblastic Leukemia News and Research

RSS
Acute lymphoblastic leukemia (ALL) is a cancer of the white blood cells, the cells in the body that normally fight infections. There are two main types of white blood cells-lymphoid cells and myeloid cells. ALL affects lymphoid cells.
CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

Clinical study uses genetic testing to match AML patients with new therapies

Clinical study uses genetic testing to match AML patients with new therapies

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

UNC Lineberger professor receives The Leukemia & Lymphoma Society grant for immunotherapy research

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

Russian scientists uncover previously unknown effect of leukemia drug

Russian scientists uncover previously unknown effect of leukemia drug

Adipocytes may reduce effectiveness of chemotherapeutic drug

Adipocytes may reduce effectiveness of chemotherapeutic drug

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Researchers develop new way to genetically engineer T cells for treating leukemia relapse

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

New CAR-T cell therapy offers effective option for certain blood cancer patients

New CAR-T cell therapy offers effective option for certain blood cancer patients

Cascade of costs could push new gene therapy above $1 million per patient

Cascade of costs could push new gene therapy above $1 million per patient

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

Study provides detailed characterization of neurotoxicity arising from CD19 CAR T-cell therapy

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

BU professor receives $792,000 grant to study about aggressiveness of T-ALL

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

New gene therapy to treat cancer in children, young adults offers hopes and challenges

New gene therapy to treat cancer in children, young adults offers hopes and challenges

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Diet and exercise have potential to improve chemotherapy effectiveness in pediatric cancer patients

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

Inactivation of Capicua gene leads to formation of T-ALL tumors in mice, researchers find

Spot Leukaemia campaign launched to reduce delays in diagnosis

Spot Leukaemia campaign launched to reduce delays in diagnosis

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

UChicago Medicine working with Novartis to offer breakthrough gene therapy for pediatric ALL patients

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL

FDA makes the first gene therapy Kymriah available for treatment of pediatric ALL